Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.56634 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.46073 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.47497 | 58 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.35126 | 56 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.37505 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.55447 | 57 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.6451 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.63604 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.43492 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.42371 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.46656 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.42803 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.46648 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.46791 | 57 |